Cost-effectiveness: let's get "real"

Comment

S R Lemkin. J Clin Oncol. 1996 Feb.

. 1996 Feb;14(2):687-8.

doi: 10.1200/JCO.1996.14.2.687.

No abstract available

Comment on

Economic evaluation of a randomized clinical trial comparing vinorelbine, vinorelbine plus cisplatin, and vindesine plus cisplatin for non-small-cell lung cancer.
Smith TJ, Hillner BE, Neighbors DM, McSorley PA, Le Chevalier T. Smith TJ, et al. J Clin Oncol. 1995 Sep;13(9):2166-73. doi: 10.1200/JCO.1995.13.9.2166. J Clin Oncol. 1995. PMID: 7666075 Clinical Trial.
Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.
Le Chevalier T, Brisgand D, Douillard JY, Pujol JL, Alberola V, Monnier A, Riviere A, Lianes P, Chomy P, Cigolari S, et al. Le Chevalier T, et al. J Clin Oncol. 1994 Feb;12(2):360-7. doi: 10.1200/JCO.1994.12.2.360. J Clin Oncol. 1994. PMID: 8113844 Clinical Trial.